Cookies on our website

We use cookies on our website. To learn more about cookies, how we use them on our site and how to change your cookie settings please view our cookie policy.

Read more Close
Skip Ribbon Commands
Skip to main content
You searched for:
Search

Search

1-4 of 4 results
Results per page: 
Sort by: 
Today’s Autumn Statement saw financial institutions hit by a surprise proposal to limit the proportion of their profits which can be reduced by the carry forward of past losses, which will mean tax is paid on those profits earlier than it would otherwise have been.
04 December 2014
http://www.allenovery.com/publications/en-gb/Pages/UK-Autumn-Statement-2014.aspx
Allen & Overy LLP berät Novartis beim Verkauf ihrer 43%-igen Beteiligung an der LTS Lohmann Therapiesysteme AG (LTS) an dievini Hopp BioTech holding GmbH & Co. KG (dievini).
18 July 2014
http://www.allenovery.com/news/de-de/articl … kauf-der-LTS-Lohmann-Therapiesysteme-AG.aspx
Allen & Overy LLP advises Novartis on the disposal of its 43% stake in LTS Lohmann Therapie-Systeme AG (LTS) to dievini Hopp BioTech holding GmbH & Co. KG (dievini).
18 July 2014
http://www.allenovery.com/news/en-gb/articl … kauf-der-LTS-Lohmann-Therapiesysteme-AG.aspx
Recently, the Tax Justice Network sent a letter to every CEO in the FTSE 100 to tell them about a legal opinion they obtained from a firm of solicitors.
13 September 2013
http://www.allenovery.com/news/en-gb/articles/Pages/No-duty-to-avoid-tax---No-kidding.aspx


  • Add comment (optional)